...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Topoisomerase Mutations Associated with In Vitro Selection of Resistance to Moxifloxacin in Streptococcus pneumoniae.
【24h】

Topoisomerase Mutations Associated with In Vitro Selection of Resistance to Moxifloxacin in Streptococcus pneumoniae.

机译:与肺炎链球菌对莫西沙星耐药性的体外选择相关的拓扑异构酶突变。

获取原文
获取原文并翻译 | 示例
           

摘要

We analyzed the frequencies of selection, the order of acquisition, and the mutations selected on moxifloxacin in two wild-type pneumococcal strains, R6 and 5714. The first selection step showed either a single GyrA mutation or no mutation in any of the quinolone resistance-determining regions. Second-step mutants selected had either a second mutation in ParC or in ParE. Moxifloxacin could belong to these fluoroquinolones, which preferentially target GyrA though probably acting equally through both gyrase and topoisomerase IV.
机译:我们分析了两种野生型肺炎球菌R6和5714菌株的选择频率,获取顺序和在莫西沙星上选择的突变。第一步选择显示任何GyrA突变或任何喹诺酮耐药性无突变-确定区域。选择的第二步突变体在ParC或ParE中具有第二个突变。莫西沙星可能属于这些氟喹诺酮类药物,尽管可能同时通过回旋酶和拓扑异构酶IV起作用,但它们优先靶向GyrA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号